Inovio Pharmaceuticals (United States)
- World rank, all time
- #12,970 of 42,892
- Rank in United States
- #2,835 of 8,685
- Research works
- 150 ▼ 38% vs 2013–17
- Citations
- 5.5k 36.4 per fractional work
- Top-10% rate
- 33.0% record average 16.5%
- Open access
- 54% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.2×. Every wedge is a field page.
Who are the top researchers at Inovio Pharmaceuticals (United States)?
Ranked on the composite score, Kate E. Broderick, Niranjan Y. Sardesai and Laurent Humeau lead among researchers whose main affiliation is Inovio Pharmaceuticals (United States).
- 1 Kate E. Broderick United States · #314,216 worldwide 71 citations · 23 works
- 2 Niranjan Y. Sardesai United States · #432,304 worldwide 65 citations · 30 works
- 3 Laurent Humeau United States · #593,398 worldwide 59 citations · 19 works
- 4 Matthew P. Morrow United States · #764,344 worldwide 24 citations · 22 works
Which keywords describe research at Inovio Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Immunity, Immune Response, Gene Therapy, Vaccine, Epidemiology, Antigen Presentation, Cancer Immunotherapy and Innate Immunity.
- HPV Vaccination
- Cancer Incidence
- Viral Transmission
- ACE2 Receptor
- Ricin Poisoning
- Gene Silencing
- SARS-CoV-2
- Antiretroviral Therapy
- Antibodies
- Vaccine Development
- Cancer Therapy
- Irreversible Electroporation
- Pathogenesis
- Plant Molecular Farming
- Biopharmaceuticals
- Tumor Antigen
- Innate Immunity
- Antigen Presentation
- Gene Therapy
- Immunity
- Epidemiology
- Immune Response
- Vaccine
- Cancer Immunotherapy
- Dendritic Cells
- Vaccine Adjuvants
- Recombinant Proteins
- Vaccine Antigens
- Electroporation
- Global Burden
- Pandemic
- Coronavirus
- Human Papillomavirus
- Antiviral Therapy
- Targeted Therapy
- Immunotoxin
- Liver Disease
- Cervical Cancer
- AIDS
- HIV
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology24▲ 3.9×36 topics
- Immunity18▲ 35×5 topics
- Immune Response18▲ 19×15 topics
- Gene Therapy18▲ 44×4 topics
- Vaccine17▲ 28×11 topics
- Antigen Presentation17▲ 112×2 topics
- Cancer Immunotherapy15▲ 73×2 topics
- Innate Immunity15▲ 29×4 topics
- Dendritic Cells14▲ 79×2 topics
- Tumor Antigen14▲ 110×1 topic
- Vaccine Adjuvants14▲ 110×1 topic
- Biopharmaceuticals10▲ 102×3 topics
- Recombinant Proteins10▲ 129×2 topics
- Plant Molecular Farming10▲ 264×1 topic
- Vaccine Antigens10▲ 264×1 topic
- Pathogenesis10▲ 11×13 topics
- Electroporation9▲ 274×1 topic
- Irreversible Electroporation9▲ 274×1 topic
- Global Burden8▲ 10×3 topics
- Cancer Therapy7▲ 7.7×7 topics
- Pandemic6▲ 9.1×4 topics
- Vaccine Development6▲ 13×7 topics
- Coronavirus6▲ 33×3 topics
- Antibodies6▲ 42×2 topics
- Human Papillomavirus6▲ 29×3 topics
- Antiretroviral Therapy5▲ 15×3 topics
- Antiviral Therapy5▲ 23×3 topics
- SARS-CoV-25▲ 24×5 topics
- Targeted Therapy5▲ 16×5 topics
- Gene Silencing5▲ 27×2 topics
- Immunotoxin5▲ 101×1 topic
- Ricin Poisoning5▲ 101×1 topic
- Liver Disease5▲ 23×2 topics
- ACE2 Receptor5▲ 26×2 topics
- Cervical Cancer5▲ 31×2 topics
- Viral Transmission5▲ 32×2 topics
- AIDS4▲ 56×1 topic
- Cancer Incidence4▲ 21×1 topic
- HIV4▲ 25×1 topic
- HPV Vaccination4▲ 58×1 topic
Which research topics does Inovio Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Medical Imaging and Pathology Studies and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
- 2 Immunotherapy and Immune Responses Immunology 1 works
- 3 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 1 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 5 Animal Virus Infections Studies Animal Science and Zoology 0 works
- 6 Cervical Cancer and HPV Research Epidemiology 0 works
- 7 Hepatitis B Virus Studies Epidemiology 0 works
- 8 SARS-CoV-2 detection and testing Infectious Diseases 0 works
- 9 Microbial Inactivation Methods Biotechnology 0 works
- 10 vaccines and immunoinformatics approaches Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Inovio Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 38% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Plymouth Meeting
- ECRI Institute
- The Institute of Addiction Medicine
- Genaera (United States)
- Premier Dental Products (United States)
- Quietmind Foundation
- Claneil Foundation
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.